This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dana Chreng
Director, Manufacturing & Operations at Ionis
Speaker

Profile

Dana Chreng is Director of Manufacturing & Operations at Ionis Pharmaceuticals where he is responsible for managing oligonucleotide process development/optimization of downstream operations as well as the scaleup of these processes for GMP production. His areas of focus include solution-phase detritylation, drug-ligand conjugation, and product isolation strategies. Dana has a BS and MS in chemical engineering from Stanford University and has been in the industry for over 15 years, all at Ionis.